Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report

Recommended treatment for attention deficit hyperactivity disorder (ADHD) includes stimulant medication. While these medicines are effective for most ADHD patients, benefits may wear off, suggesting tolerance. This paper reviews the published literature on tolerance to stimulant medication treatment...

Full description

Bibliographic Details
Main Authors: Kenneth Handelman, Fernando Sumiya
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/12/8/959
_version_ 1797411062077718528
author Kenneth Handelman
Fernando Sumiya
author_facet Kenneth Handelman
Fernando Sumiya
author_sort Kenneth Handelman
collection DOAJ
description Recommended treatment for attention deficit hyperactivity disorder (ADHD) includes stimulant medication. While these medicines are effective for most ADHD patients, benefits may wear off, suggesting tolerance. This paper reviews the published literature on tolerance to stimulant medication treatment for ADHD. As there are relatively few studies published, pivotal studies and ADHD treatment guidelines were also reviewed. Research demonstrates physiological changes related to continued stimulant usage in neurons and certain brain regions, suggesting a mechanism for tolerance development. One clinical study showed that 24.7% of patients developed tolerance to stimulants in the time of days to weeks; another showed 2.7% developed tolerance over 10 years. Long term follow-up studies demonstrate that medication response may lessen over longer durations of treatment in a high percentage of patients. Strategies to manage tolerance include switching stimulant medicines, drug holidays, or clinical reassessment. Three cases illustrate challenges with treating patients who develop tolerance to stimulant medication. The paucity of research and lack of guidance to clinicians may contribute to significant under recognition of tolerance to stimulant medication. Further research is required to define clinical tolerance for stimulants in ADHD and to provide guidance on identifying and managing tolerance in clinical practice.
first_indexed 2024-03-09T04:39:34Z
format Article
id doaj.art-f1e25703627649fab172b418f39fc2b9
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-09T04:39:34Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-f1e25703627649fab172b418f39fc2b92023-12-03T13:23:23ZengMDPI AGBrain Sciences2076-34252022-07-0112895910.3390/brainsci12080959Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case ReportKenneth Handelman0Fernando Sumiya1Centre for Integrative Mental Health, Assistant Clinical Professor of Psychiatry, McMaster University, Hamilton, ON L8N 3K7, CanadaADHD Fellowship, Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON L8S 3L8, CanadaRecommended treatment for attention deficit hyperactivity disorder (ADHD) includes stimulant medication. While these medicines are effective for most ADHD patients, benefits may wear off, suggesting tolerance. This paper reviews the published literature on tolerance to stimulant medication treatment for ADHD. As there are relatively few studies published, pivotal studies and ADHD treatment guidelines were also reviewed. Research demonstrates physiological changes related to continued stimulant usage in neurons and certain brain regions, suggesting a mechanism for tolerance development. One clinical study showed that 24.7% of patients developed tolerance to stimulants in the time of days to weeks; another showed 2.7% developed tolerance over 10 years. Long term follow-up studies demonstrate that medication response may lessen over longer durations of treatment in a high percentage of patients. Strategies to manage tolerance include switching stimulant medicines, drug holidays, or clinical reassessment. Three cases illustrate challenges with treating patients who develop tolerance to stimulant medication. The paucity of research and lack of guidance to clinicians may contribute to significant under recognition of tolerance to stimulant medication. Further research is required to define clinical tolerance for stimulants in ADHD and to provide guidance on identifying and managing tolerance in clinical practice.https://www.mdpi.com/2076-3425/12/8/959stimulant medicationADHDtolerancemethylphenidateamphetamines
spellingShingle Kenneth Handelman
Fernando Sumiya
Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report
Brain Sciences
stimulant medication
ADHD
tolerance
methylphenidate
amphetamines
title Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report
title_full Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report
title_fullStr Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report
title_full_unstemmed Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report
title_short Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report
title_sort tolerance to stimulant medication for attention deficit hyperactivity disorder literature review and case report
topic stimulant medication
ADHD
tolerance
methylphenidate
amphetamines
url https://www.mdpi.com/2076-3425/12/8/959
work_keys_str_mv AT kennethhandelman tolerancetostimulantmedicationforattentiondeficithyperactivitydisorderliteraturereviewandcasereport
AT fernandosumiya tolerancetostimulantmedicationforattentiondeficithyperactivitydisorderliteraturereviewandcasereport